EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthetic antibodies targeting EphA2 induce diverse signaling‐competent clusters with differential activation

Jarrett J Adams iD, Heather A Bruce, Suryasree Subramania, Lynda Ploder, Julia Garcia, Isabelle Pot, Levi L Blazer, Alexander U Singer, Sachdev S Sidhu

Protein Science · 2025-06 · 34 (6)

DOI: 10.1002/pro.70145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, online erschienen am 24.05.2025. Verfasst von Jarrett J Adams und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada. Hauptthemen laut MEDLINE: Receptor, EphA2, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ontario Ministry of Research and Innovation, CIHR, Rivkin Center for Ovarian Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The receptor tyrosine kinase EphA2 interacts with ephrin (Efn) ligands to mediate bi‐directional signals that drive cellular sorting processes during tissue development. In the context of various cancers, EphA2 can also drive invasive metastatic disease and represents an important target for cancer therapeutics. Natural Efn ligands sterically seed intertwined EphA2 clusters capable of recruiting intracellular kinases to mediate trans‐phosphorylation. Synthetic proteins, such as antibodies (Abs), can mimic Efn ligands to trigger EphA2 signaling, leading to receptor internalization and degradation, and enabling intracellular delivery of conjugated drugs. Furthermore, Abs are capable of recruiting EphA2 into clusters distinct from those seeded by Efn. We developed three synthetic Abs targeting distinct EphA2 domains and determined the paratope valency necessary for agonist or antagonist properties of each of the three epitopes. Structural modeling of monovalent Fabs in complex with EphA2 elucidated competitive and non‐competitive mechanisms of inhibition of EphA2 canonical signaling. Likewise, modeling of clusters induced by bivalent IgGs elucidated multiple signaling‐competent EphA2 clusters capable of triggering a continuum of signaling strengths and provided insights into the requirement for multimerization of EphA2 to trigger phosphorylation. Our study shows how different agonist clusters lead to distinct kinase recruitment efficiencies to modify phosphotyrosine signal strength, and provides a panel of anti‐EphA2 Abs as reagents for the development of therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, EphA2Signal TransductionHumansPhosphorylationModels, Molecular

Stichwörter der Autor:innen

EfnEphEphA2antibodymechanismphage displayreceptor clusteringreceptor tyrosine kinasesignaling

Substanzen

Receptor, EphA2EPHA2 protein, human

Autor:innen und Institutionen

  • School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada.

ORCID-Profile: Jarrett J Adams

Förderung

  • Ontario Ministry of Research and Innovation
  • CIHR
  • Rivkin Center for Ovarian Cancer
  • Canada Foundation for Innovation
  • Genome Canada
  • Canadian Institutes of Health Research

Zitieren

APA

Adams, J. J., Bruce, H. A., Subramania, S., Ploder, L., Garcia, J., Pot, I., Blazer, L. L., Singer, A. U., & Sidhu, S. S. (2025). Synthetic antibodies targeting EphA2 induce diverse signaling‐competent clusters with differential activation. Protein Science, 34(6). https://doi.org/10.1002/pro.70145

Vancouver

Adams JJ, Bruce HA, Subramania S, Ploder L, Garcia J, Pot I, et al. Synthetic antibodies targeting EphA2 induce diverse signaling‐competent clusters with differential activation. Protein Science. 2025;34(6). doi:10.1002/pro.70145

BibTeX
@article{Adams2025,
  author = {Adams, Jarrett J and Bruce, Heather A and Subramania, Suryasree and Ploder, Lynda and Garcia, Julia and Pot, Isabelle and Blazer, Levi L and Singer, Alexander U and Sidhu, Sachdev S},
  title = {Synthetic antibodies targeting EphA2 induce diverse signaling‐competent clusters with differential activation},
  journal = {Protein Science},
  year = {2025},
  volume = {34},
  number = {6},
  doi = {10.1002/pro.70145}
}
Kostenlos starten →